Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D0K8KJ
|
||||
| Former ID |
DIB016419
|
||||
| Drug Name |
DuP-129
|
||||
| Synonyms |
ACAT inhibitors, Du Pont
|
||||
| Indication | Hypercholesterolemia [ICD10:E78] | Terminated | [545519] | ||
| Company |
Bristol-Myers Squibb Pharma Co
|
||||
| Canonical SMILES |
C1(N=C(N([C@@H]1CC(=O)C1CCCCC1)C)c1ccc(cc1)F)(C(F)(F)F)<br />C(F)(F)F
|
||||
| Target and Pathway | |||||
| Target(s) | Liver carboxylesterase | Target Info | Inhibitor | [543651] | |
| KEGG Pathway | Drug metabolism - other enzymes | ||||
| Metabolic pathways | |||||
| Pathway Interaction Database | E2F transcription factor network | ||||
| References | |||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Tang and Dr. Zhang.